Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)
Clinical trial NCT03485287 · COMPLETED
Trial details
- NCT number
- NCT03485287
- Sponsor
- Resilient Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-13
- Primary completion
- 2019-06-04
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.